Matches in Wikidata for { <http://www.wikidata.org/entity/Q91298807> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91298807 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91298807 description "bài báo khoa học" @default.
- Q91298807 description "scientific article published on 25 October 2019" @default.
- Q91298807 description "wetenschappelijk artikel" @default.
- Q91298807 description "наукова стаття, опублікована 25 жовтня 2019" @default.
- Q91298807 description "գիտական հոդված հրատարակված 2019 թվականի հոկտեմբերի 25-ին" @default.
- Q91298807 name "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 name "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 type Item @default.
- Q91298807 label "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 label "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 prefLabel "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 prefLabel "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 P1433 Q91298807-8C5A8980-3FDE-466E-B3F7-C5ED852C7274 @default.
- Q91298807 P1476 Q91298807-6BABFAA3-4F2B-42C9-A936-2E2EE38279C3 @default.
- Q91298807 P2093 Q91298807-15874271-5078-4500-96EE-66EFB3CB3F78 @default.
- Q91298807 P2093 Q91298807-22171205-9612-4A35-8014-3E4994A7CDBD @default.
- Q91298807 P2093 Q91298807-57AD87F9-B58C-47A6-96CF-9EF0A0B83789 @default.
- Q91298807 P2093 Q91298807-7376453E-D088-48BC-8D58-B533EA9F2C2B @default.
- Q91298807 P2093 Q91298807-90692D58-EC46-471D-AECF-40A0D0955502 @default.
- Q91298807 P2093 Q91298807-ABFBE65D-22BB-4C3D-84BF-C6453489FE19 @default.
- Q91298807 P2093 Q91298807-CFAD951D-C5A1-477E-B86D-79E91C29DE22 @default.
- Q91298807 P275 Q91298807-521ee767-281b-4a88-a3a9-fa96f3f29db4 @default.
- Q91298807 P31 Q91298807-4ED22F35-95C4-43F0-97FB-B15DD3AD3EFB @default.
- Q91298807 P356 Q91298807-F2147DD8-F392-4BC6-8826-B6ACDC518CC6 @default.
- Q91298807 P433 Q91298807-9237F336-1085-4930-90C2-DD079AF7C689 @default.
- Q91298807 P478 Q91298807-6A454092-C1DE-49C4-9443-965B99C04E2C @default.
- Q91298807 P50 Q91298807-0EB22063-8C72-4C8B-A573-91B999555690 @default.
- Q91298807 P50 Q91298807-1E81F096-CE3C-4811-923A-7AACEE40A228 @default.
- Q91298807 P50 Q91298807-31DFB59C-9DF3-434E-A78D-0E6907C9F9B8 @default.
- Q91298807 P50 Q91298807-3629CE38-C7F5-43B3-8D39-BDF1C89B3CD9 @default.
- Q91298807 P50 Q91298807-DC30BCEE-0118-42E1-B512-3C361DF47552 @default.
- Q91298807 P577 Q91298807-F553933C-3144-472E-B096-BA4447C5D453 @default.
- Q91298807 P6216 Q91298807-33968ad5-ef74-4614-9680-774552e94b51 @default.
- Q91298807 P698 Q91298807-0129CB26-2425-4B8A-8A17-E2C4E4F633D8 @default.
- Q91298807 P921 Q91298807-01F67A03-8B54-433E-AFD5-42791FF18BAB @default.
- Q91298807 P921 Q91298807-73A8E1D6-BCEA-442F-BD40-F37DC29A7EF7 @default.
- Q91298807 P932 Q91298807-27E94573-2F07-4A6E-8A93-9E4FC2EB785A @default.
- Q91298807 P356 NU11112580 @default.
- Q91298807 P698 31731527 @default.
- Q91298807 P1433 Q7070485 @default.
- Q91298807 P1476 "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
- Q91298807 P2093 "Angelo M Patti" @default.
- Q91298807 P2093 "Antonella Amato" @default.
- Q91298807 P2093 "Dragana Nikolic" @default.
- Q91298807 P2093 "Giuseppa Castellino" @default.
- Q91298807 P2093 "Giuseppe Montalto" @default.
- Q91298807 P2093 "Manfredi Rizzo" @default.
- Q91298807 P2093 "Roberta Chianetta" @default.
- Q91298807 P275 Q20007257 @default.
- Q91298807 P31 Q13442814 @default.
- Q91298807 P356 "10.3390/NU11112580" @default.
- Q91298807 P433 "11" @default.
- Q91298807 P478 "11" @default.
- Q91298807 P50 Q11765283 @default.
- Q91298807 P50 Q40927042 @default.
- Q91298807 P50 Q60473383 @default.
- Q91298807 P50 Q63974885 @default.
- Q91298807 P50 Q90128856 @default.
- Q91298807 P577 "2019-10-25T00:00:00Z" @default.
- Q91298807 P6216 Q50423863 @default.
- Q91298807 P698 "31731527" @default.
- Q91298807 P921 Q269829 @default.
- Q91298807 P921 Q657193 @default.
- Q91298807 P932 "6893885" @default.